|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01276 HENGRUI PHARMA
Nominal 
75.100 -3.750 (-4.756%) Ranking Overview
Ranking based on 3 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
0
|
Buy (2)
3
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2024 | EPS | 100.00 RMB (cts) | |
| Net Profit | 6,336.53 RMB (MIL) | DPS | -- RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2025 | 8,495.00 | 131.00 | 19.00 | -- | 8,790.00 | 8,455.65 |
| 2026 | 10,288.87 | 159.00 | 24.00 | -- | 10,533.00 | 10,150.00 |
| 2027 | 12,063.65 | 187.00 | 28.00 | -- | 12,468.00 | 11,924.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2025 | 8,495.00 | 131.00 | 38.00 | UBS | Buy | 87.30 | 28/07/2025 | |
| 2025 | 8,455.65 | 127.00 | -- | MORGAN STANLEY | Overweight | 85.00 | 20/07/2025 | |
| 2025 | 8,790.00 | 138.00 | -- | NOMURA | Buy | 80.57 | 28/07/2025 | |
| 2026 | 10,533.00 | 159.00 | 48.00 | UBS | -- | -- | 28/07/2025 | |
| 2026 | 10,288.87 | 155.00 | -- | MORGAN STANLEY | -- | -- | 20/07/2025 | |
| 2026 | 10,150.00 | 159.00 | -- | NOMURA | -- | -- | 28/07/2025 | |
| 2027 | 12,468.00 | 188.00 | 56.00 | UBS | -- | -- | 28/07/2025 | |
| 2027 | 12,063.65 | 182.00 | -- | MORGAN STANLEY | -- | -- | 20/07/2025 | |
| 2027 | 11,924.00 | 187.00 | -- | NOMURA | -- | -- | 28/07/2025 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 01/08/2025 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |